Dynamics in Post-pandemic Global Over-The-Counter(OTC) Drugs Industry: Supply and Demand, Markets and Prices 2021-2027
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global Over-The-Counter(OTC) Drugs Market Status and Forecast (2016-2027)
- 1.3.2 Global Over-The-Counter(OTC) Drugs Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global Over-The-Counter(OTC) Drugs Supply by Company
- 2.1 Global Over-The-Counter(OTC) Drugs Sales Volume by Company
- 2.2 Global Over-The-Counter(OTC) Drugs Sales Value by Company
- 2.3 Global Over-The-Counter(OTC) Drugs Price by Company
- 2.4 Over-The-Counter(OTC) Drugs Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional Over-The-Counter(OTC) Drugs Market Status by Category
- 3.1 Over-The-Counter(OTC) Drugs Category Introduction
- 3.1.1 Cold and Flu Products
- 3.1.2 Analgesics
- 3.1.3 Dermatological Products
- 3.1.4 Gastrointestinal Products
- 3.1.5 Vitamin
- 3.1.6 Other
- 3.2 Global Over-The-Counter(OTC) Drugs Market by Category
- 3.2.1 Global Over-The-Counter(OTC) Drugs Sales Volume by Category (2016-2021)
- 3.2.2 Global Over-The-Counter(OTC) Drugs Sales Value by Category (2016-2021)
- 3.2.3 Global Over-The-Counter(OTC) Drugs Price by Category (2016-2021)
- 3.3 North America: by Category
- 3.4 Europe: by Category
- 3.5 Asia Pacific: by Category
- 3.6 Central & South America: by Category
- 3.7 Middle East & Africa: by Category
4 Global and Regional Over-The-Counter(OTC) Drugs Market Status by End User/Segment
- 4.1 Over-The-Counter(OTC) Drugs Segment by End User/Segment
- 4.1.1 Hospital Pharmacy
- 4.1.2 Retail Pharmacy
- 4.1.3 Online Pharmacy
- 4.2 Global Over-The-Counter(OTC) Drugs Market by End User/Segment
- 4.2.1 Global Over-The-Counter(OTC) Drugs Sales Volume by End User/Segment (2016-2021)
- 4.2.2 Global Over-The-Counter(OTC) Drugs Sales Value by End User/Segment (2016-2021)
- 4.2.3 Global Over-The-Counter(OTC) Drugs Price by End User/Segment (2016-2021)
- 4.3 North America: by End User/Segment
- 4.4 Europe: by End User/Segment
- 4.5 Asia Pacific: by End User/Segment
- 4.6 Central & South America: by End User/Segment
- 4.7 Middle East & Africa: by End User/Segment
5 Global Over-The-Counter(OTC) Drugs Market Status by Region
- 5.1 Global Over-The-Counter(OTC) Drugs Market by Region
- 5.1.1 Global Over-The-Counter(OTC) Drugs Sales Volume by Region
- 5.1.2 Global Over-The-Counter(OTC) Drugs Sales Value by Region
- 5.2 North America Over-The-Counter(OTC) Drugs Market Status
- 5.3 Europe Over-The-Counter(OTC) Drugs Market Status
- 5.4 Asia Pacific Over-The-Counter(OTC) Drugs Market Status
- 5.5 Central & South America Over-The-Counter(OTC) Drugs Market Status
- 5.6 Middle East & Africa Over-The-Counter(OTC) Drugs Market Status
6 North America Over-The-Counter(OTC) Drugs Market Status
- 6.1 North America Over-The-Counter(OTC) Drugs Market by Country
- 6.1.1 North America Over-The-Counter(OTC) Drugs Sales Volume by Country (2016-2021)
- 6.1.2 North America Over-The-Counter(OTC) Drugs Sales Value by Country (2016-2021)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe Over-The-Counter(OTC) Drugs Market Status
- 7.1 Europe Over-The-Counter(OTC) Drugs Market by Country
- 7.1.1 Europe Over-The-Counter(OTC) Drugs Sales Volume by Country (2016-2021)
- 7.1.2 Europe Over-The-Counter(OTC) Drugs Sales Value by Country (2016-2021)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific Over-The-Counter(OTC) Drugs Market Status
- 8.1 Asia Pacific Over-The-Counter(OTC) Drugs Market by Country
- 8.1.1 Asia Pacific Over-The-Counter(OTC) Drugs Sales Volume by Country (2016-2021)
- 8.1.2 Asia Pacific Over-The-Counter(OTC) Drugs Sales Value by Country (2016-2021)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America Over-The-Counter(OTC) Drugs Market Status
- 9.1 Central & South America Over-The-Counter(OTC) Drugs Market by Country
- 9.1.1 Central & South America Over-The-Counter(OTC) Drugs Sales Volume by Country (2016-2021)
- 9.1.2 Central & South America Over-The-Counter(OTC) Drugs Sales Value by Country (2016-2021)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa Over-The-Counter(OTC) Drugs Market Status
- 10.1 Middle East & Africa Over-The-Counter(OTC) Drugs Market by Country
- 10.1.1 Middle East & Africa Over-The-Counter(OTC) Drugs Sales Volume by Country (2016-2021)
- 10.1.2 Middle East & Africa Over-The-Counter(OTC) Drugs Sales Value by Country (2016-2021)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 Over-The-Counter(OTC) Drugs Manufacturing Cost Analysis
- 11.5 Over-The-Counter(OTC) Drugs Sales Channel and Distributors Analysis
- 11.5.1 Over-The-Counter(OTC) Drugs Sales Channel
- 11.5.2 Over-The-Counter(OTC) Drugs Distributors
- 11.6 Over-The-Counter(OTC) Drugs Downstream Major Buyers
12 Global Over-The-Counter(OTC) Drugs Market Forecast by Category and by End User/Segment
- 12.1 Global Over-The-Counter(OTC) Drugs Sales Volume and Sales Value Forecast (2022-2027)
- 12.2 Global Over-The-Counter(OTC) Drugs Forecast by Category
- 12.2.1 Global Over-The-Counter(OTC) Drugs Sales Volume Forecast by Category
- 12.2.2 Global Over-The-Counter(OTC) Drugs Sales Value Forecast by Category
- 12.2.3 Global Over-The-Counter(OTC) Drugs Price Forecast by Category
- 12.3 Global Over-The-Counter(OTC) Drugs Forecast by End User/Segment
- 12.3.1 Global Over-The-Counter(OTC) Drugs Sales Volume Forecast by End User/Segment
- 12.3.2 Global Over-The-Counter(OTC) Drugs Sales Value Forecast by End User/Segment
- 12.3.3 Global Over-The-Counter(OTC) Drugs Price Forecast by End User/Segment
13 Global Over-The-Counter(OTC) Drugs Market Forecast by Region/Country
- 13.1 Global Over-The-Counter(OTC) Drugs Market Forecast by Region (2022-2027)
- 13.1.1 Global Over-The-Counter(OTC) Drugs Sales Volume Forecast by Region (2022-2027)
- 13.1.2 Global Over-The-Counter(OTC) Drugs Sales Value Forecast by Region (2022-2027)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Teva Pharmaceuticals
- 14.1.1 Company Information
- 14.1.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.1.3 Teva Pharmaceuticals Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.1.4 SWOT Analysis
- 14.2 Takeda
- 14.2.1 Company Information
- 14.2.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.2.3 Takeda Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.2.4 SWOT Analysis
- 14.3 Sun Pharmaceutical Industries
- 14.3.1 Company Information
- 14.3.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.3.3 Sun Pharmaceutical Industries Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.3.4 SWOT Analysis
- 14.4 Sanofi
- 14.4.1 Company Information
- 14.4.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.4.3 Sanofi Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.4.4 SWOT Analysis
- 14.5 PGT healthcare
- 14.5.1 Company Information
- 14.5.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.5.3 PGT healthcare Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.5.4 SWOT Analysis
- 14.6 Pfizer
- 14.6.1 Company Information
- 14.6.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.6.3 Pfizer Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.6.4 SWOT Analysis
- 14.7 Novartis
- 14.7.1 Company Information
- 14.7.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.7.3 Novartis Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.7.4 SWOT Analysis
- 14.8 Innovus Pharmaceuticals
- 14.8.1 Company Information
- 14.8.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.8.3 Innovus Pharmaceuticals Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.8.4 SWOT Analysis
- 14.9 GSK
- 14.9.1 Company Information
- 14.9.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.9.3 GSK Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.9.4 SWOT Analysis
- 14.10 Glenmark
- 14.10.1 Company Information
- 14.10.2 Over-The-Counter(OTC) Drugs Product Introduction
- 14.10.3 Glenmark Over-The-Counter(OTC) Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.10.4 SWOT Analysis
- 14.11 Cipla
- 14.12 Boehringer Ingelheim
- 14.13 Bayer
15 Conclusion
16 Methodology
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Over-The-Counter(OTC) Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Over-The-Counter(OTC) Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
Segmented by End User/Segment
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Teva Pharmaceuticals
Takeda
Sun Pharmaceutical Industries
Sanofi
PGT healthcare
Pfizer
Novartis
Innovus Pharmaceuticals
GSK
Glenmark
Cipla
Boehringer Ingelheim
Bayer